权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Lifespan Regulation by Inter-Organellar Heme Signaling

细胞间血红素信号传导的寿命调节

基本信息

批准号：
10722824
负责人：
Iqbal Hamza
金额：
$ 38.22万
依托单位：
GEORGIA INSTITUTE OF TECHNOLOGY
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-08-01 至 2028-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10722824
关键词：
Address Age Aging Animal Model Animals Binding Biochemical Biochemical Genetics Biological Biological Availability Biophysics Caenorhabditis elegans Catalysis Cell Aging Cell model Cells Cellular biology Chelating Agents Collaborations Communication Data Dietary Iron Disease Dissociation Electron Transport Endowment Enterocytes Exhibits Funding Gases Gene Deletion Genes Genetic Heme Heme Iron Homeostasis Hydrophobicity Ion Channel Iron Laboratories Lipids Location Longevity Mass Spectrum Analysis Mediating Membrane Metabolic Microbe Mitochondria Modeling Molecular Molecular Genetics Neurons Nucleic Acids Nutrient Organ Organelles Oxidative Stress Pathway interactions Phosphotransferases Process Property Proteins Proteomics Publishing RNA Interference Regulation Respiration Role Saccharomyces cerevisiae Signal Transduction Signaling Molecule Site Source Testing Therapeutic Intervention Tissues Transition Elements Yeasts cofactor cytotoxic extracellular genetic approach healthspan inhibitor mitochondrial dysfunction mitochondrial metabolism mutant novel novel therapeutics proteostasis receptor response sensor trafficking transcription factor transmission process

项目摘要

PROJECT SUMMARY The long-term objectives of this proposal are to elucidate heme signaling networks that regulate the metabolic adaption to aging and control lifespan. The canonical function of heme in cell biology is as a protein cofactor. More recent studies indicate that heme may act as a dynamic signaling molecule. Previous studies have shown that there is a decline in heme concentration in several cell and animal models of aging, and this decline is associated with various hallmarks of aging, including mitochondrial dysfunction, oxidative stress, and diminished lifespan. In our recent unpublished studies, we found that limiting cellular heme dramatically increases lifespan in cell (Saccharomyces cerevisiae) and animal (Caenorhabditis elegans) models of aging. However, the mechanisms by which heme regulates lifespan are not known. The current proposal integrates genetically encoded heme sensors, heme chelators, mass spectrometry approaches, and molecular genetics, to probe the role of heme in aging and the mechanisms it acts through to control lifespan. In particular, we seek to identify the targets of heme signaling that control lifespan, the mechanisms that mediate inter-organelle and inter-organ heme transfer to regulate lifespan, and the subcellular and tissue/organ locations where heme signaling operates to respond to aging and control lifespan. Two specific aims are proposed in which the role of heme in cellular and animal aging will be probed in Saccharomyces cerevisiae, a cell model, (Aim 1) and in Caenorhabditis elegans, an animal model (Aim 2). In Aim 1, to elucidate the mechanisms of inter-organelle heme signaling in a yeast cell model of aging, we will (a) identify the targets of heme signaling using complementary genetic and hemoproteomics approaches, (b) determine the subcellular location where heme is sourced for heme signaling, and elucidate inter-organellar heme trafficking pathways using gene-deletion and proteomics screens. In Aim 2, to elucidate the mechanisms of inter-organ heme signaling in a worm animal model of aging, we will (a) determine the role of heme and heme responsive genes (hrgs) in modifying lifespan in long-lived [daf-2] and short-lived [daf-16] worm mutants, (b) identify the sender and receiver cells of heme signaling in control of lifespan using tissue-restricted genetically encoded heme sensors in long-lived and short-lived mutants, (c) assess organ and subcellular labile heme pools that control lifespan, and deploy hemoproteomics to identify novel targets of heme signaling that could control lifespan and assess the impact of these candidate interactors on heme signaling The current proposal will be the first to comprehensively decipher the role of heme in aging and may lead to new heme-based therapeutic interventions that can be used to slow aging or treat age associated diseases.

项目总结